🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Naoki Haratake

Harvard University

ORCID: 0000-0002-3098-4798

Also affiliated with Oita University, National Hospital Organization Kyushu Cancer Center, Dana-Farber Cancer Institute

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 12 papers. Top paper: “MUC1-C Dictates PBRM1-Mediated Chronic Induction of Interferon Signaling, DNA Damage Resistance, and Immunosuppression in Triple-Negative Breast Cancer”.

MUC1-C Dictates PBRM1-Mediated Chronic Induction of Interferon Signaling, DNA Damage Resistance, and Immunosuppression in Triple-Negative Breast Cancer

Molecular Cancer Research(2022)10.1158/1541-7786.mcr-22-0772
N/A
0.542DataRank · unranked
36 citations

Yoshihiro Morimoto, Atsushi Fushimi, Rehan Ahmad, Atrayee Bhattacharya, Tatsuaki Daimon +15 more

XIST and MUC1-C form an auto-regulatory pathway in driving cancer progression

Cell Death and Disease(2024)10.1038/s41419-024-06684-9
N/A
0.487DataRank · unranked
14 citations

Atrayee Bhattacharya, Naoki Haratake, Tatsuaki Daimon, Ayako Nakashoji, Hiroki Ozawa +4 more

MUCIN 1 confers inflammatory memory of tyrosine kinase inhibitor resistance in non-small cell lung cancer

Signal Transduction and Targeted Therapy(2025)10.1038/s41392-025-02482-7
N/A
0.211DataRank · unranked
3 citations

Naoki Haratake, Atrayee Bhattacharya, Chie Kikutake, Hiroki Ozawa, Keisuke Shigeta +15 more

MUC1-C is necessary for SHP2 activation and BRAF inhibitor resistance in BRAF(V600E) mutant colorectal cancer

Cancer Letters(2023)10.1016/j.canlet.2023.216116
N/A
0DataRank · unranked
21 citations

Nami Yamashita, Haruka Hirose, Atsushi Fushimi, Naoki Haratake, Tatsuaki Daimon +6 more

MUC1-C is a target of salinomycin in inducing ferroptosis of cancer stem cells

Cell Death Discovery(2024)10.1038/s41420-023-01772-9
N/A
0DataRank · unranked
12 citations

Atrayee Bhattacharya, Keyi Wang, Naoki Haratake, Ayako Nakashoji, Hiroki Ozawa +6 more

IDENTIFICATION OF MUC1-C AS A TARGET FOR SUPPRESSING PROGRESSION OF HEAD AND NECK SQUAMOUS CELL CARCINOMAS

Cancer Research Communications(2024)10.1158/2767-9764.crc-24-0011
N/A
0DataRank · unranked
5 citations

Naoki Haratake, Atrayee Bhattacharya, Weipu Mao, Kangjie Xu, Keyi Wang +13 more

MUC1-C dependence in treatment-resistant prostate cancer uncovers a target for antibody-drug conjugate therapy

JCI Insight(2025)10.1172/jci.insight.190924
N/A
0DataRank · unranked
10 citations

Tatsuaki Daimon, Hiroshi Hongo, Sheng-Yu Ku, Hiroki Ozawa, Naoki Haratake +14 more

Activation of APOBEC3 cytidine deaminases and endogenous retroviruses is integrated by MUC1-C in NSCLC cells

Cell Death Discovery(2025)10.1038/s41420-025-02673-9
N/A
0DataRank · unranked
6 citations

Shinkichi Takamori, Hideko Isozaki, Keisuke Shigeta, Chie Kikutake, Hiroki Ozawa +9 more

MUC1-C auto-regulatory complex with EBNA1 is responsible for latent Epstein-Barr virus-associated gastric cancer progression

Oncogene(2025)10.1038/s41388-025-03519-5
N/A
0DataRank · unranked
4 citations

Yin Wang, Henry Withers, Naoki Haratake, Ayako Nakashoji, Atrayee Bhattacharya +14 more

MUC1-C dependency in drug resistant HR+/HER2− breast cancer identifies a new target for antibody-drug conjugate treatment

npj Breast Cancer(2025)10.1038/s41523-025-00751-w
N/A
0DataRank · unranked
6 citations

Atrayee Bhattacharya, Hiroki Ozawa, Naoki Haratake, Keisuke Shigeta, Atsushi Fushimi +16 more

MUC1-C integrates aerobic glycolysis with suppression of oxidative phosphorylation in triple-negative breast cancer stem cells

iScience(2023)10.1016/j.isci.2023.108168
N/A
0DataRank · unranked
14 citations

Henry Withers, Yoshihiro Morimoto, Atrayee Bhattacharya, Naoki Haratake, Tatsuaki Daimon +8 more

MUC1-C is a master regulator of MICA/B NKG2D ligand and exosome secretion in human cancer cells

Journal for ImmunoTherapy of Cancer(2023)10.1136/jitc-2022-006238
N/A
0DataRank · unranked
25 citations

Nami Yamashita, Tatsuaki Daimon, Haruka Hirose, Shizuka Yamano, Naoki Haratake +9 more